Indian Pharmaceutical Alliance Seeks to Regularize 'Legacy' Drugs Marketed Without Central Approval

Pharmaceuticals

5 August 2026 at 5:53 am

Indian Pharmaceutical Alliance Seeks to Regularize 'Legacy' Drugs Marketed Without Central Approval

HyperFast News

Summary

The Indian Pharmaceutical Alliance (IPA) is seeking to regularize numerous 'legacy' drugs, such as sodium valproate and carbamazepine tablets, which have been marketed for years without central approval due to persistent regulatory gaps.

Select what you want to create

Turn this story into an image post, carousel, video, audio reel, blog, and more — all from HyperFast News.

FAQ

Newsroom FAQs

About the public HyperFast News news feed powered by NewsEngine.

Indian Pharmaceutical Alliance Seeks to Regularize 'Legacy' Drugs Marketed Without Central Approval | HyperFast News